Key Takeaways Chipmakers Intel and Micron extended their rallies Monday, following record closings achieved on Thursday Getty Images skyrocketed 179% following the announcement of a multi-yea
Chipmakers Intel and Micron continued their upward momentum Monday morning, extending a powerful rally that saw both securities reach all-time peaks during Thursday’s trading session.
Intel climbed 4.4% during early market activity. The semiconductor giant had surged 10.6% on Thursday following President Donald Trump’s disclosure that the company had finalized a manufacturing agreement with Apple, propelling shares to a historic closing price of $133.99.
Micron advanced more than 3%. Market participants are keeping close tabs on the memory chip manufacturer as it prepares to deliver its quarterly earnings results on Wednesday, an event widely anticipated as potentially pivotal for the stock’s trajectory.
Additional artificial intelligence-focused hardware companies also registered gains in premarket activity. Super Micro Computer, Western Digital, Sandisk, Seagate Technology, and Corning all traded higher.
The day’s most dramatic single-stock movement came from Getty Images, which exploded 179% higher after unveiling a multi-year collaboration with OpenAI.
Under the agreement, Getty’s extensive collection of licensed visual assets will be embedded directly into ChatGPT’s search and content discovery functionality. Platform users will receive legally verified imagery within their query responses, representing a significant evolution in how artificial intelligence systems obtain visual materials.
Market observers view this partnership as a fundamental transformation of Getty’s operating model, and shareholders reacted enthusiastically.
Apogee Therapeutics climbed more than 50% to $139.38 following a Financial Times report indicating that AbbVie has entered advanced acquisition discussions valued at approximately $11 billion in cash.
The potential transaction focuses on Apogee’s primary drug candidate, zumilokibart, an anti-inflammatory compound under development as a competitive alternative to Dupixent, the highly successful eczema medication marketed by Sanofi and Regeneron.
AbbVie gained 4.2% on the disclosure. Should the transaction be finalized, it would bolster AbbVie’s development portfolio in inflammatory disease treatments.
Arcosa similarly moved higher, advancing 11.5%, following reports that Irish construction materials conglomerate CRH is nearing an acquisition valued at over $8 billion.
Not all technology companies participated in Monday’s gains. SpaceX retreated 3.7% in premarket activity, positioning the stock for its third straight daily decline.
Alphabet, Amazon, Tesla, Nvidia, and Broadcom all traded lower ahead of Monday’s opening bell.
Equity futures displayed mixed readings as investors monitored ongoing diplomatic discussions between the United States and Iran taking place in Switzerland. Negotiators reported the talks are yielding “encouraging progress,” with both nations committing to a 60-day framework toward a comprehensive agreement and measures to maintain uninterrupted oil transit through the Strait of Hormuz.
Nextpower slipped 2% after revealing plans to acquire German solar infrastructure provider Zimmermann PV-Steel Group for as much as €330 million. Investors appeared hesitant about integration challenges associated with the cash-and-equity deal, which is projected to conclude during the second half of 2027.
The post Market Highlights: Getty Images Soars 179% on OpenAI Partnership, AbbVie Plans $11B Acquisition appeared first on Blockonomi.
